The polymorphisms of DNA G-quadruplex investigated by docking experiments with telomestatin enantiomers

Current Pharmaceutical Design

Volumn 18, Issue 14, 2012, Pages 1873-1879

  Alcaro, Stefano ^a   Costa, Giosuè ^a   Distinto, Simona ^a   Moraca, Federica ^a   Ortuso, Francesco ^a   Parrotta, Lucia ^a   Artese, Anna ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

DNA; Docking; G quadruplex; Geometrical Descriptor; Polymorphism; Telomestatin

Indexed keywords

GUANINE QUADRUPLEX; TELOMESTATIN;

ARTICLE; DNA FLANKING REGION; DNA POLYMORPHISM; ENANTIOMER; EXPERIMENTAL MODEL; HUMAN; ISOMER; MOLECULAR DOCKING; NUCLEOTIDE BINDING SITE; PRIORITY JOURNAL; TELOMERE; THERMODYNAMICS;

BINDING SITES; DNA; G-QUADRUPLEXES; HUMANS; MODELS, MOLECULAR; OXAZOLES; STEREOISOMERISM; TELOMERE;

EID: 84860143899     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161212799958495     Document Type: Article

References (68)

1. McElligott R, Wellinger RJ. The terminal DNA structure of mammalian chromosomes. EMBO J 1997; 16: 3705-3714.
2. Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature 1990; 345: 458-460.
3. Burge S, Parkinson GN, Hazel P, Todd AK, Neidle S. Quadruplex DNA: sequence, topology and structure. Nucleic Acids Res 2006; 34: 5402-5415.
4. Levy MZ, Allsopp RC, Futcher AB, Greider CW, Harley CB. Telomere end-replication problem and cell aging. J Mol Biol 1992; 225: 951-960.
5. Bisoffi M, Heaphy CM, Griffith JK. Telomeres: Prognostic markers for solid tumors. Int J Cancer 2006; 119: 2255-2260.
6. Kelland LR. Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics - current status and future prospects. Eur J Cancer 2005; 41: 971-979.
7. Olaussen KA, Dubrana K, Domont J, Spano J-P, Sabatier L, Soria J-C. Telomeres and telomerase as targets for anticancer drug development. Crit Rev Oncol Hematol 2006; 57: 191-214.
8. Patel DJ, Phan AT, Kuryavyi V. Human telomere, oncogenic promoter and 5'-UTR G-quadruplexes: diverse higher order DNA and RNA targets for cancer therapeutics. Nucleic Acids Res 2007; 35: 7429-7455.
9. Engelhart AE, Plavec J, Persil O, Hud NV. Chapter 4 Metal ion interactions with G-quadruplex structures. In: ed.eds., Nucleic Acid-Metal Ion Interactions. The Royal Society of Chemistry 2009; pp. 118-153.
10. Neidle S. The structures of quadruplex nucleic acids and their drug complexes. Curr Opin Struct Biol 2009; 19: 239-250.
11. http://www.rcsb.org/
12. Wang Y, Patel DJ. Solution structure of the human telomeric repeat d[AG3(T2AG3)3] G-tetraplex. Structure 1993; 1: 263-282.
13. Parkinson GN, Lee MPH, Neidle S. Crystal structure of parallel quadruplexes from human telomeric DNA. Nature 2002; 417: 876-880.
14. Phan AT, Patel DJ. Two-repeat human telomeric d(TAGGGTTAGGGT) sequence forms interconverting parallel and antiparallel G-quadruplexes in solution: distinct topologies, thermodynamic properties, and folding/unfolding kinetics. J Am Chem Soc 2003; 125: 15021-15027.
15. Ying L, Green JJ, Li H, Klenerman D, Balasubramanian S. Studies on the structure and dynamics of the human telomeric G quadruplex by single-molecule fluorescence resonance energy transfer. Proc Natl Acad Sci USA 2003; 100: 14629-14634.
16. Xu Y, Sugiyama H. Highly efficient photochemical 2'-deoxyribonolactone formation at the diagonal loop of a 5-iodouracil-containing antiparallel G-quartet. J Am Chem Soc 2004; 126: 6274-6279.
17. Hazel P, Huppert J, Balasubramanian S, Neidle S. Loop-length-dependent folding of G-quadruplexes. J Am Chem Soc 2004; 126: 16405-16415.
18. Rezler EM, Seenisamy J, Bashyam S, Kim M-Y, White E, Wilson WD, Hurley LH. Telomestatin and diseleno sapphyrin bind selectively to two different forms of the human telomeric G-quadruplex structure. J Am Chem Soc 2005; 127: 9439-9447.
19. Rujan IN, Meleney JC, Bolton PH. Vertebrate telomere repeat DNAs favor external loop propeller quadruplex structures in the presence of high concentrations of potassium. Nucleic Acids Res 2005; 33: 2022-2031.
20. Qi J, Shafer RH. Covalent ligation studies on the human telomere quadruplex. Nucleic Acids Res 2005; 33: 3185-3192.
21. Ourliac-Garnier I, Elizondo-Riojas M-A, Redon S, Farrell NP, Bombard S. Cross-links of quadruplex structures from human telomeric DNA by dinuclear platinum complexes show the flexibility of both structures. Biochemistry 2005; 44: 10620-10634.
22. Lee JY, Okumus B, Kim DS, Ha T. Extreme conformational diversity in human telomeric DNA. Proc Natl Acad Sci USA 2005; 102: 18938-18943.
23. Yu H-Q, Miyoshi D, Sugimoto N. Characterization of structure and stability of long telomeric DNA G-quadruplexes. J Am Chem Soc 2006; 128: 15461-15468.
24. Dai J, Punchihewa C, Ambrus A, Chen D, Jones RA, Yang D. Structure of the intramolecular human telomeric G-quadruplex in potassium solution: a novel adenine triple formation. Nucleic Acids Res 2007; 35: 2440-2450.
25. Dai J, Carver M, Punchihewa C, Jones RA, Yang D. Structure of the Hybrid-2 type intramolecular human telomeric G-quadruplex in K+ solution: insights into structure polymorphism of the human telomeric sequence. Nucleic Acids Res 2007; 35: 4927-4940.
26. Phan AT, Kuryavyi V, Luu KN, Patel DJ. Structure of two intramolecular G-quadruplexes formed by natural human telomere sequences in K+ solution. Nucleic Acids Res 2007; 35: 6517-6525.
27. Ambrus A, Chen D, Dai J, Bialis T, Jones RA, Yang D. Human telomeric sequence forms a hybrid-type intramolecular G-quadruplex structure with mixed parallel/antiparallel strands in potassium solution. Nucleic Acids Res 2006; 34: 2723-2735.
28. Luu KN, Phan AT, Kuryavyi V, Lacroix L, Patel DJ. Structure of the human telomere in K+ solution: an Intramolecular (3 + 1) G-quadruplex scaffold. J Am Chem Soc 2006; 128: 9963-9970.
29. Phan AT, Luu KN, Patel DJ. Different loop arrangements of intramolecular human telomeric (3+1) G-quadruplexes in K+ solution. Nucleic Acids Res 2006; 34: 5715-5719.
30. Sun D, Thompson B, Cathers BE, et al. Inhibition of human telomerase by a G-quadruplex-interactive compound. J Med Chem 1997; 40: 2113-2116.
31. Shay JW, Wright WE. Telomerase therapeutics for cancer: challenges and new directions. Nat Rev Drug Discov 2006; 5: 577-584.
32. Oganesian L, Bryan TM. Physiological relevance of telomeric G-quadruplex formation: a potential drug target. BioEssays 2007; 29: 155-165.
33. De Cian A, Lacroix L, Douarre C, et al. Targeting telomeres and telomerase. Biochimie 2008; 90: 131-155.
34. Monchaud D, Teulade-Fichou MP. A hitchhiker's guide to G-quadruplex ligands. Org Biomol Chem 2008; 6: 627-636.
35. Alcaro S, Artese A, Costa G, Distinto S, Ortuso F, Parrotta L. Conformational studies and solvent-accessible surface area analysis of known selective DNA G-Quadruplex binders. Biochimie 2011; In Press, Corrected Proof.
36. Shin-ya K, Wierzba K, Matsuo K, et al. Telomestatin, a novel telomerase inhibitor from Streptomyces anulatus. J Am Chem Soc 2001; 123: 1262-1263.
37. Kim MY, Vankayalapati H, Shin-ya K, Wierzba K, Hurley LH. Telomestatin, a potent telomerase inhibitor that interacts quite specifically with the human telomeric intramolecular G-quadruplex. J Am Chem Soc 2002; 124: 2098-2099.
38. Perry PJ, Read MA, Davies RT, et al. 2,7-Disubstituted amidofluorenone derivatives as inhibitors of human telomerase. J Med Chem 1999; 42: 2679-2684.
39. Koeppel F, Riou JF, Laoui A, et al. Ethidium derivatives bind to G-quartets, inhibit telomerase and act as fluorescent probes for quadruplexes. Nucleic Acids Res 2001; 29: 1087-1096.
40. Harrison RJ, Reszka AP, Haider SM, et al. Evaluation of by disubstituted acridone derivatives as telomerase inhibitors: the importance of G-quadruplex binding. Bioorg Med Chem Lett 2004; 14: 5845-5849.
41. Harrison RJ, Gowan SM, Kelland LR, Neidle S. Human telomerase inhibition by substituted acridine derivatives. Bioorg Med Chem Lett 1999; 9: 2463-2468.
42. Fedoroff OY, Salazar M, Han H, Chemeris VV, Kerwin SM, Hurley LH. NMR-based model of a telomerase-inhibiting compound bound to G-quadruplex DNA. Biochemistry 1998; 37: 12367-12374.
43. Duan W, Rangan A, Vankayalapati H, et al. Design and synthesis of fluoroquinophenoxazines that interact with human telomeric G-quadruplexes and their biological effects. Mol Cancer Ther 2001; 1: 103-120.
44. Mehta AK, Shayo Y, Vankayalapati H, Hurley LH, Schaefer J. Structure of a quinobenzoxazine-G-quadruplex complex by REDOR NMR. Biochemistry 2004; 43: 11953-11958.
45. Alberti P, Schmitt P, Nguyen CH, et al. Benzoindoloquinolines interact with DNA tetraplexes and inhibit telomerase. Bioorg Med Chem Lett 2002; 12: 1071-1074.
46. Caprio V, Guyen B, Opoku-Boahen Y, et al. A novel inhibitor of human telomerase derived from 10H-indolo[3,2-b]quinoline. Bioorg Med Chem Lett 2000; 10: 2063-2066.
47. Guyen B, Schultes CM, Hazel P, Mann J, Neidle S. Synthesis and evaluation of analogues of 10H-indolo[3,2-b]quinoline as G-quadruplex stabilising ligands and potential inhibitors of the enzyme telomerase. Org Biomol Chem 2004; 2: 981-988.
48. Guittat L, Alberti P, Rosu F, et al. Interactions of cryptolepine and neocryptolepine with unusual DNA structures. Biochimie 2003; 85: 535-547.
49. Zhou JL, Lu YJ, Ou TM, et al. Synthesis and evaluation of quindoline derivatives as G-quadruplex inducing and stabilizing ligands and potential inhibitors of telomerase. J Med Chem 2005; 48: 7315-7321.
50. Shi DF, Wheelhouse RT, Sun D, Hurley LH. Quadruplex interactive agents as telomerase inhibitors: synthesis of porphyrins and structure-activity relationship for the inhibition of telomerase. J Med Chem 2001; 44: 4509-4523.
51. Mergny JL, Lacroix L, Teulade-Fichou MP, et al. Telomerase inhibitors based on quadruplex ligands selected by a fluorescence assay. Proc Natl Acad Sci USA 2001; 98: 3062-3067.
52. Riou JF, Guittat L, Mailliet P, et al. Cell senescence and telomere shortening induced by a new series of specific G-quadruplex DNA ligands. Proc Natl Acad Sci USA 2002; 99: 2672-2677.
53. Chang CC, Kuo IC, Ling IF, et al. Detection of quadruplex DNA structures in human telomeres by a fluorescent carbazole derivative. Anal Chem 2004; 76: 4490-4494.
54. Alcaro S, Artese A, Iley JN, et al. Tetraplex DNA specific ligands based on the fluorenone-carboxamide scaffold. Bioorg Med Chem Lett 2007; 17: 2509-2514.
55. Alcaro S, Artese A, Iley JN, et al. Rational design, synthesis, biophysical and antiproliferative evaluation of fluorenone derivatives with DNA G-quadruplex binding properties. ChemMedChem 2010; 5: 575-583.
56. Doi T, Shibata K, Yoshida M, et al. S-Stereoisomer of telomestatin as a potent G-quadruplex binder and telomerase inhibitor. Org Biomol Chem 2011; 9: 387-393.
57. Alcaro S, Gasparrini F, Incani O, Mecucci S, Misiti D, Pierini M, Villani C. A quasi-flexible automatic docking processing for studying stereoselective recognition mechanisms. Part I. Protocol validation. J Comput Chem 2000; 21: 515-530.
58. Alcaro S, Gasparrini F, Incani O, Caglioti L, Pierini M, Villani C. Quasi flexible automatic docking processing for studying stereoselective recognition mechanisms, part 2: Prediction of Delta Delta G of complexation and H1-NMR NOE correlation. J Comput Chem 2007; 28: 1119-1128.
59. Morris GM, Goodsell DS, Halliday RS, et al. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J Comput Chem 1998; 19: 1639-1662.
60. Clark GR, Pytel PD, Squire CJ, Neidle S. Structure of the first parallel DNA quadruplex-drug complex. J Am Chem Soc 2003; 125: 4066-4067.
61. Monchaud D, Granzhan A, Saettel N, Guedin A, Mergny JL, Teulade-Fichou MP. One ring to bind them all-part I: the efficiency of the macrocyclic scaffold for g-quadruplex DNA recognition. Journal of nucleic acids 2010; 2010.
62. Maestro 4.1. Schrçdinger Inc.: Portland OR USA 2001
63. Mohamadi F, Richards NGJ, Guida WC, et al. Macromodel-an integrated software system for modeling organic and bioorganic molecules using molecular mechanics. J Comput Chem 1990; 11: 440-467.
64. McDonald DQ, Still WC. AMBER torsional parameters for the peptide backbone. Tetrahedron Lett 1992; 33: 7743-7746.
65. Still C, Tempczyk A, Hawley R, Hendrickson T. Semianalytical treatment of solvation for molecular mechanics and dynamics. J Am Chem Soc 1990; 112: 6127-6129.
66. WL. The PyMOL Molecular Graphics System 2002, http://www.pymol.org
67. Campbell NH, Parkinson GN, Reszka AP, Neidle S. Structural basis of DNA quadruplex recognition by an acridine drug. J Am Chem Soc 2008; 130: 6722-6724.
68. Hounsou C, Guittat L, Monchaud D, et al. G-Quadruplex recognition by quinacridines: a SAR, NMR, and biological study. ChemMedChem 2007; 2: 655-666.